References
- Ahmad Al Obaidi, A.H., et al., 2008. The predictive value of IgE as biomarker in asthma. The journal of asthma, 45, 654–663.
- American Thoracic Society, European Respiratory Society 2005. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. American journal of respiratory and critical care medicine, 171, 912–930.
- Chen, X., et al., 2012. Secreted microRNAs: a new form of intercellular communication. Trends in cell biology, 22, 125–132.
- Chiappori, A., et al., 2015. Biomarkers and severe asthma: a critical appraisal. Clinical and molecular allergy, 13, 20.
- Corren, J., 2013. Asthma phenotypes and endotypes: an evolving paradigm for classification. Discovery medicine, 15, 243–249.
- Haccuria, A., et al., 2014. Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes. Journal of allergy and clinical immunology, 134, 554–559.
- Heffler, E., et al., 2017. MicroRNA profiling in asthma: potential biomarkers and therapeutic targets. American journal of respiratory cell and molecular biology, 57, 642–650.
- Ho, S.M., 2010. Environmental epigenetics of asthma: an update. The journal of allergy and clinical immunology, 126, 453–465.
- Hoffmeyer, F., et al., 2015. Different patterns in changes of exhaled breath condensate ph and exhaled nitric oxide after ozone exposure. Advances in experimental medicine and biology, 834, 39–47.
- Liu, Y., et al., 2018. Next generation sequencing for miRNA profile of spleen CD4 + T cells in the murine model of acute asthma. Epigenomics, 10:1071–1083.
- Lötvall, J., et al., 2011. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. The journal of allergy and clinical immunology, 127, 355–360.
- Maes, T., et al., 2016. Asthma inflammatory phenotypes show differential microRNA expression in sputum. The journal of allergy and clinical immunology, 137, 1433–1446.
- Milger, K., et al., 2017. Identification of a plasma miRNA biomarker signature for allergic asthma: a translational approach. Allergy, 72, 1962–1971.
- Mitchell, P.S., et al., 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America, 105, 10513–10518.
- Parks, C.G., et al., 2010. Total serum IgE levels in systemic lupus erythematosus and associations with childhood onset allergies. Lupus, 19, 1614–1622.
- Patterson, K., and Strek, M.E., 2010. Allergic bronchopulmonary aspergillosis. Proceedings of the American Thoracic Society, 7, 237–244.
- Perry, M.M., Adcock, I.M., and Chung, K.F., 2015. Role of microRNAs in allergic asthma: present and future. Current opinion in allergy and clinical immunology, 15, 156–162.
- Rebane, A., and Akdis, C.A., 2013. MicroRNAs: Essential players in the regulation of inflammation. The journal of allergy and clinical immunology, 132, 15–26.
- Rebane, A., and Akdis, C.A., 2014. MicroRNAs in allergy and asthma. Current allergy and asthma reports, 14, 424.
- Sin, B., and Togias, A., 2011. Pathophysiology of allergic and nonallergic rhinitis. Proceedings of the American Thoracic Society, 8, 106–114.
- Tu, Y.L., et al., 2013. Total serum IgE in a population-based study of Asian children in Taiwan: reference value and significance in the diagnosis of allergy. PLoS one, 8, e80996.
- Wahid, F., et al., 2010. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochimica et biophysica acta, 1803, 1231–1243.
- Wenzel, S.E., 2012. Asthma phenotypes: the evolution from clinical to molecular approaches. Nature medicine, 18, 716–725.
- Woodruff, P.G., 2013. Subtypes of asthma defined by epithelial cell expression of messenger RNA and microRNA. Annals of the American Thoracic Society, 10 Suppl, S186–S189.
- Wu, X.B., et al., 2014. Overexpression of microRNA-21 and microRNA-126 in the patients of bronchial asthma. International journal of clinical and experimental medicine, 7, 1307–1312.